Tuesday, July 23, 2019
wellness India Expo
Home Tags MedGenome

Tag: MedGenome

Neeraj Bhargava joins MedGenome Board of Directors

Neeraj, an alumnus of St. Stephens, Delhi, is the founder, CEO and Senior Managing Director of Zodius Capital Advisors. Zodius is an early investor in MedGenome.....................

MedGenome expands its presence in Mumbai by taking over Centre For...

With this take over, it will be able to provide patients with a wide range of molecular tests across all the specialties like Reproductive, Neurology, Nephrology, Oncology, Cardiology, ENT, Endocrinology, Ophthalmology, rare diseases etc...…………..

Researchers discover genetic mutation causing rare colorectal disorder in Gujarati family

This is a first-of-its-kind genetic study in India on a rare inherited condition involving a patient diagnosed with Familial Adenomatous Polyposis (FAP) and 25 members of his immediate and extended family................

Genomics revolution set to transform modern healthcare

Armed with the knowledge from decades-long genome sequencing projects besides latest ongoing initiatives, India can develop health strategies that are specific to genomic variations within the Indian population..............

Clinicians discuss the benefits of PGS/PGD in IVF pregnancies

The pre-implantation genetic screening/diagnosis (PGS/D) during Invitro Fertilization greatly reduces the chances of miscarriage and other complications such as a baby being born with trisomy 21, which results in Downs Syndrome................

MedGenome receives accreditation from College of American Pathologists

The CAP accreditation is awarded to clinical laboratories meeting the highest standards in quality laboratory practices..........

MedGenome launches novel genetic screening test for unborn babies

The genetic test developed in collaboration with Sir Ganga Ram Hospitals is targeted at inherited diseases in Indian population......

MedGenome’s ONCOTRACK: the liquid biopsy blood test for cancer recurrence detection

The test facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy.....

MedGenome first in SE Asia to acquire Illumina Hiseq X Ten...

The genomics firm, MedGenome has become the first company in South-East Asia to acquire high throughput Illumina's Hiseq X Ten platform...

Revolutionary alternative to unnecessary invasive prenatal screening tests

Is it time for India to use the latest technology developments to help prevent pregnant women from undergoing unnecessary invasive prenatal....